See more : Perimeter Medical Imaging AI, Inc. (PYNKF) Income Statement Analysis – Financial Results
Complete financial analysis of Lunit Inc. (328130.KQ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Lunit Inc., a leading company in the industry within the sector.
- Big Sky Growth Partners, Inc. (BSKYW) Income Statement Analysis – Financial Results
- Source Natural Foods and Herbal Supplements Limited (SOURCENTRL.BO) Income Statement Analysis – Financial Results
- Pagaria Energy Limited (WOMENNET.BO) Income Statement Analysis – Financial Results
- Golden Faith Group Holdings Limited (2863.HK) Income Statement Analysis – Financial Results
- Vahanna Tech Edge Acquisition I Corp. (VHNA) Income Statement Analysis – Financial Results
Lunit Inc. (328130.KQ)
Website: https://www.lunit.io
About Lunit Inc.
Lunit Inc. develops and provides AI based software solutions for cancer screening/diagnosis and treatment. It offers AI solution for chest X-ray and mammography, as well as AI-powered biomarker for immune phenotyping and PD-L1 quantification for immunotherapy. The company was incorporated in 2013 and is based in Seoul, South Korea.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 25.08B | 13.87B | 6.64B | 1.43B | 198.40M |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 25.08B | 13.87B | 6.64B | 1.43B | 198.40M |
| Gross Profit Ratio | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Research & Development | 16.64B | 18.36B | 22.30B | 9.06B | 4.55B |
| General & Administrative | 3.31B | 2.04B | 1.85B | 565.00M | 5.54B |
| Selling & Marketing | 11.19B | 7.94B | 5.51B | 2.39B | 1.32B |
| SG&A | 14.50B | 9.98B | 7.36B | 2.96B | 6.86B |
| Other Expenses | 36.16B | 31.42M | -4.55B | 170.27M | 0.00 |
| Operating Expenses | 67.30B | 64.55B | 52.34B | 22.37B | 45.50B |
| Cost & Expenses | 67.30B | 64.55B | 52.34B | 22.37B | 45.50B |
| Interest Income | 2.74B | 1.48B | 144.77M | 229.93M | 1.67B |
| Interest Expense | 2.01B | 1.19B | 2.33B | 3.32B | 1.75B |
| Depreciation & Amortization | 3.77B | 3.04B | 2.07B | 1.32B | 374.86M |
| EBITDA | -30.98B | -34.89B | -47.83B | -19.40B | -11.22B |
| EBITDA Ratio | -123.53% | -251.25% | -720.41% | -1,356.26% | -5,656.90% |
| Operating Income | -42.22B | -50.65B | -45.70B | -20.95B | -11.60B |
| Operating Income Ratio | -168.33% | -365.30% | -688.36% | -1,465.03% | -5,845.84% |
| Total Other Income/Expenses | 5.45B | 11.53B | -27.98B | -62.79B | -35.37B |
| Income Before Tax | -36.76B | -39.12B | -73.68B | -83.74B | -46.97B |
| Income Before Tax Ratio | -146.58% | -282.12% | -1,109.74% | -5,855.73% | -23,675.02% |
| Income Tax Expense | 34.59M | 12.77B | -4.19B | 234.39M | 0.00 |
| Net Income | -36.80B | -39.12B | -73.68B | -83.74B | -46.97B |
| Net Income Ratio | -146.72% | -282.12% | -1,109.74% | -5,855.73% | -23,675.02% |
| EPS | -1.43K | -1.75K | -5.58K | -10.98K | -7.28K |
| EPS Diluted | -1.43K | -1.75K | -5.58K | -10.98K | -7.28K |
| Weighted Avg Shares Out | 25.72M | 22.33M | 13.19M | 7.63M | 6.46M |
| Weighted Avg Shares Out (Dil) | 25.72M | 22.33M | 13.19M | 7.63M | 6.46M |
Source: https://incomestatements.info
Category: Stock Reports